World Journal of Cardiology. Aug/25/2017; 9(8): 652-666

Published online Aug/25/2017

PMID: 28932354

PMC: 5583538

doi: 10.4330/wjc.v9.i8.652

Cardiovascular involvement in celiac disease

Abstract

Core tip: Celiac disease (CD) is a public health concern suffered by about 1% of the population worldwide. It often goes undetected even in developed countries, owing to the varied and occult presentation which can make diagnosis difficult. Untreated, systemic manifestations including cardiovascular ailments can occur. In this review, information concerning the cardiovascular involvement in CD patients is described and discussed. Treatment of CD patients with a gluten free diet can reverse some, but not all of the cardiovascular involvement. Thus the need for prompt diagnosis and treatment.

INTRODUCTION

Celiac disease (CD) is characterized by an immunologic response to gluten, which often results in diffuse inflammatory damage to the small intestinal mucosa, and malabsorption of nutrients[1]. CD is of special interest among chronic diseases due to several factors: (1) it is associated with specific comorbidities; (2) it involves a compromised absorption of nutrients; and (3) a gluten-free diet (GFD) is currently the main long-term treatment[2]. Studies have shown that certain cardiovascular maladies, including cardiomyopathy, myocarditis, arrhythmias, and premature atherosclerosis, are more prevalent in individuals with CD as compared to individuals without the disease[3,4]. In this article, published works concerning the effects of CD on the cardiovascular system, and the risk of cardiovascular disease, are reviewed. The method of some previous analyses is followed to quantitatively characterize the published articles[5-7], and to then compile the most salient information for review.

RESEARCH PROCEDURE

The Google Scholar search tool was used to find associations between CD and the heart and vascular systems. Keywords pertaining to the heart and vascular system, tabulated in Table 1, were used for search in conjunction with “celiac disease”, “coeliac disease”, or “gluten”. The searches were limited to the co-detection of these terms in the publication title, which is suggestive of the importance of the keywords. The cardiovascular keywords used for search were derived from encyclopedic descriptions of the heart, vascular, and cardiovascular systems. Under these headings, all relevant terms were extracted as keywords. They were categorized as heart terms and vascular terms. The format used for search in Google Scholar was, for example: (1) allintitle: “celiac disease” “myocardial”; (2) allintitle: “coeliac disease” “myocardial”; and (3) allintitle: “gluten” “myocardial”, where the results for the three forms of expression pertaining to CD were then combined. Heart and vascular keywords, tabulated in Table 1, were then combined to form summary topics for analysis. The number of CD/cardiovascular publications per year was then graphed for all of the summary topics.

Table 1

Cardiovascular terms used for search in the study

Heart terms	Vascular terms
Afterload, preload	Angiogenesis
Arrhythmia, rhythm	Aorta, aortic
Atrial, atrium	Arterial, arteries, artery
Atrioventricular	Arteriosclerosis, atherosclerosis
Bachmann’s	Atherogenesis, atherogenic
Cardiac, cardio	Blood pressure
Cardiologist	Cardiovascular
Cardiomyopathies, cardiomyopathy	Circulatory
Congenital	Circumflex
Contractility	Coronary
Depolarization	Embolism
Effusion	Haemoptysis, hemoptysis
Ejection	Hemorrhage
Electromechanical	Haemodynamics, Hemodynamics
Endocardium, epicardium	Haemosiderosis, hemosiderosis
Fibrillation	Stroke
Foramen ovale	Thrombosis, thromboembolism
Frank-Starling	Vascular
Heart	Vein, veins
Infarction	Vena cava
Ischaemic, ischemic	Venous
Mitral	Venule, venules
Myocardial, myocardium
Myocarditis
Myocyte
Pericardial, pericardium
Purkinje
QT
Septum
Sinoatrial
Stenosis
Tachycardia
Tricuspid
Valve, valves, valvular

The type of published document was also recorded for each keyword entry. Each citation used was categorized by type of published documentation as shown in Table 2. There are six possible publication types according to the list. All published documents were categorized as one of the types noted in Table 2. Graphical displays were utilized to separately show the number of CD/cardiovascular documents of each type noted in Table 2 that were published per year. Then for each of the summary topics, the total number of publications of each type in Table 2 were compiled. Also for each of the summary topics, the total number of studies and the mean publication year of the studies for the journals the studies were published in were tabulated. The essential points in each study were then condensed and described in review form, in separate sections, for each of the summary topics.

Table 2

Categories of published documents

Type	Description
Articles	Includes research articles, cohort studies and case control studies
Reviews	These included reviews of the literature and meta-analyses
Case studies	Limited to n = 1-3 patients in the study
Letters	These could include comments on other articles as well as case reports in letter form
Abstracts	When no full paper had been published, abstracts were included in the references
Editorials	These were typically comments on papers published in the same journal issue

PUBLICATION SUMMARY STATISTICS

In Figure 1 is presented a graph of the number of publications per year in which CD and cardiovascular terms appeared. The earliest studies in which CD was investigated for cardiovascular function were published in 1970. However until the year 1998, only a handful of such studies were published, after which there began a substantial increase in the publishing of CD/cardiovascular studies. Although there were fluctuations in the number of studies in the 2000s and 2010s, the overall trend was a sharp upward swing in published studies. The data for 2017 only includes the first few weeks of the year.

Figure 1

Overall published studies on celiac disease/cardiovascular by year.

The number of studies for selected types that was published per year is shown in bar graph form in Figure 2. The results are shown for articles (cohort), case studies, abstracts, and letters, and review and editorial publications. Many of the CD/cardiovascular published studies were either articles or case studies. As for graphs of the total studies published that were shown in Figure 1, the graphs of individual published document types in Figure 2 begin to exhibit substantial increases about the year 2000. There were also a number of abstracts and case reports published in the late 1980s and 1990s, as is notable in the case reports graph in Figure 2. There are only a few review and editorial publications to date, but they are recent.

Figure 2

Published studies per year according to document type.

Based on all of this data, in Table 3 are provided, for each document type, the number of published studies for each topic, with the totals for all articles shown in the last row. Most of the published works are either articles (74) or case studies (62). There are also substantial numbers of letters (23) and abstracts (20). The totals for each term are given to the right in the table. The sum total, 190, is greater than the number of cited articles in this review, 180, because a particular citation could be used in more than one review topics section. Furthermore, several citations used in the Introduction were not cardiovascular studies and were not included in Table 3. A number of topics were particularly of interest for CD/cardiovascular publishing. These include papers on CD and cardiomyopathy (33 studies), thrombosis (27), cardiovascular risk (17), atherosclerosis (13), stroke (12), and arterial function and ischemic heart disease (11 each). In Table 4 are shown keyword terms and total number of studies, and median (range) study year of the journal. The median year for all of the studies is 2004 or later, except for the term “haemodynamics” (1998). Thus the possible connection between CD and “haemodynamics” tended to be investigated at earlier dates, as compared with other cardiovascular conditions.

Table 3

Types of studies associated with each keyword

Keyword	Article	Review	Case	Letter	Abstract	Editorial	Total
Arterial function	6	1	2	2			11
Atherosclerosis	4		1	5	3		13
Angiogenesis	6				1		7
Thrombosis	4	2	15	5	1		27
Stroke	2	2	7		1		12
Hemorrhage			7	3			10
Haemodynamics	1			1	2		4
Vascular - other	2		3				5
Pericardial effusion	2		1		1		4
Myocarditis	3	1	1	1			6
Cardiomyopathy	8	1	21	0	2	1	33
Infarction	4			1			5
Electromechanical	6				1		7
Ischemic heart disease	6			3	1	1	11
Rhythm disturbances	3		1	1	3		8
Congenital heart defect	3		1				4
Heart - other	3		2		1		6
Cardiovascular risk	11	2		1	3		17
Total	74	9	62	23	20	2	190

Table 4

Characteristics of the published studies by keyword

Category	Topic	Studies1	Median year	Range
Vascular	Arterial function	11	2014	2011-2016
Vascular	Atherosclerosis	13	2013	2008-2016
Vascular	Angiogenesis	7	2009	1970-2013
Vascular	Thrombosis	27	2007	1995-2016
Vascular	Stroke	12	2008	2001-2017
Vascular	Hemorrhage	10	2007	1997-2012
Vascular	Haemodynamics	4	1998	1993-2005
Vascular	Other	5	2004	1993-2013
Heart	Pericardial effusion	4	2008	2000-2014
Heart	Myocarditis	6	2004	2002-2012
Heart	Cardiomyopathy	33	2010	1986-2016
Heart	Infarction	5	2009	2008-2015
Heart	Electromechanical	7	2014	2008-2016
Heart	Ischemic heart disease	11	2014	2004-2016
Heart	Rhythm disturbances	8	2014	1989-2016
Heart	Congenital heart defect	4	2014	1982-2016
Heart	Other	6	2012	2004-2016
Cardiovas cular disease	Risk factors	17	2013	2007-2017

1Studies: Total number of studies published on the topic. Studies could be used as references for more than one topic.

Compilation of the celiac disease - cardiovascular literature

In this section, the study results for each keyword of Table 1 are combined into summary topics, to show the general consensus and trends for CD/cardiovascular publications. Thus the most pertinent information from all studies belonging to a particular cardiovascular term was collated by topic. The total number of studies (#) and median and range in years (median year) are shown for published studies concerning each topic. The terms are separated and noted as belonging to vascular or heart categories, followed by cardiovascular risk assessment.

Vascular - arterial function [# = 11, median year = 2014 (2011-2016)]

Arterial function is of great concern in CD. Measurements to quantify alterations are made using echocardiography and pulse wave velocity[8,9]. In untreated CD, aortic function can deteriorate, and this deterioration is predictive of subclinical atherosclerosis and future cardiovascular events[8]. Aortic strain and distensibility tend to be significantly lower, and the aortic stiffness index significantly higher, in untreated CD patients vs controls[8,10]. CD patients are at increased risk for coronary artery disease[9], which may have a genetic association[11]. Occlusion of the brachiocephalic trunk and right and left common carotid artery has been noted in CD[12]. In adult CD patients lacking cardiovascular risk factors, abnormal homocysteine, erythrocyte sedimentation rate, C-reactive protein, and insulin levels may, along with inflammation, be contributive to arterial stiffening[9]. Spontaneous coronary artery dissections have been observed as a cause of acute myocardial infarction in CD patients[3]. There is also some support for an association between CD and cerebrovascular disease[13]. Correlation has been shown between restoration of the small intestinal villous atrophy and normalization of vascular parameters in gluten-abstinent CD patients[14]. Yet after onset of the GFD, the lack of a significant reduction in aortic elastic properties suggests that some risk of cardiovascular disease may persist[10]. Type 1 diabetic patients with early presence of micro- or macrovascular complications should always be screened for CD[15]. Type I diabetes mellitus and CD can coexist, and there is evidence that microvascular complications are more severe in patients with both conditions[16,17].

Vascular - atherosclerosis [# = 13, median year = 2013 (2008-2016)]

Atherosclerosis has been linked to myocardial infarction and ischemic stroke, with chronic inflammation being a likely pathogenic factor[18]. Untreated adults with CD are at increased risk of early atherosclerosis, as suggested by the presence of chronic inflammation, vascular impairment, unfavorable biochemical patterns[19-21], and relative lack of the classical risk factors. Carotid intima-media thickness values are significantly higher in patients with coexisting diabetes and CD as compared to those patients with diabetes or CD alone[16,22]. CD youth have also been associated with increased risk of developing early atherosclerosis[19]. They are also more likely to have greater mean low density lipoprotein (LDL) cholesterol and thicker carotid intima media as compared with controls, and their endothelium-dependent dilatation is decreased, all of which negatively affect vascular function[23,24]. The GFD enables a reduction in inflammatory parameters, oxidative stress, and insulin resistance, factors that when unchecked can lead to atherosclerosis[10,25]. Gluten avoidance followed by restoration of the intestinal villi to normal function is likely to revert cardiovascular dysfunction in less than 1 years’ time[2,20,21,23,24]. Areas with improved markers on a GFD include the common carotid arteries for intima media thickness, and the humeral artery for endothelium-dependent dilatation[26]. However, patients on the GFD often show weight gain and increase in triglyceride blood levels, which suggests a risk to atherogenicity[27], although alterations of other risk factors do not necessarily support this supposition[28]. CD patients should always be encouraged to choose a healthy GFD[27].

Vascular - angiogenesis [# = 7, median year = 2009 (1970-2013)]

In untreated CD, the overall architecture of the small-bowel mucosal vasculature may be altered, leading to inhibition of angiogenesis[29]. On the GFD, the vasculature normalizes as compared to healthy subjects, in parallel to mucosal recovery, and mucosal autoantibody deposits diminish in the small intestine[29,30]. Autoantibody production in CD mainly targets against transglutaminase 2 (TG2)[29]. These autoantibodies are found in untreated CD patients’ serum[31], but also bound to extracellular TG2 below the epithelial basement membrane and around capillaries in the small intestinal mucosa, as well as in extra-intestinal organs. The autoantibodies can interfere with angiogenesis, including changes in transendothelial migration of lymphocytes[29,32,33], which is probably influenced by common genetic variants in angiogenesis-related genes[34]. In vitro, CD autoantibodies reduce endothelial branching, increase endothelial permeability to macromolecules and lymphocytes, and enhance lymphocyte adhesion to the endothelium[29,35]. Ultrastructural alterations of the small blood vessels embedded in the subepithelial connective tissue of the jejunal mucosa are most severe in CD patients not on the GFD. Similar changes occur when gluten is administered to pediatric CD patients previously on a GFD, and are one of the earliest pathological changes seen in the biopsy material[35].

Vascular - thrombosis [# = 27, median year = 2007 (1995-2016)]

Thrombotic events are increased in CD[36], can be recurrent[37], and may be present at multiple locations[38] which are observable via Doppler ultrasonographic examination[39]. Thrombophilia may result from hyperhomocysteinemia and deficiencies in protein S, folate, and vitamin B2[40-42]. The thrombotic events in CD may also result from dehydration due to diarrhea[43]. Cerebral venous sinus thrombosis can occur in CD patients[40,44-46], even in absence of gastrointestinal symptoms[45], but can resolve with symptomatic treatment[40]. Venous thrombosis can be a sequela of undetected CD[42,47-54], and may result in thromboembolic events[48,55]. CD may be accompanied by portal vein thrombosis[56,57], and mesenteric[58] or splenic[59] vein thrombosis may present in occult or subclinical celiac disease[58]. There is an increased risk of developing venous thromboembolism from chronic inflammation and vitamin deficiency in CD[44,60,61]. On a GFD, there is favorable evolution of young CD patients with thrombosis[62]. CD should be considered in young patients with thrombosis, especially if the event occurs in an unusual location[62].

Vascular - stroke [# = 12, median year = 2008 (2001-2017)]

Patients with CD have been found to be at an increased risk for stroke, which can persist after onset of the GFD[63,64]. Stroke events can be recurrent[65]. Cerebral infarction and transient hemiplegia may also present in untreated asymptomatic CD patients[66]. CD should be considered as a possible etiology for stroke cases of unknown cause, particularly in youth, whether gastrointestinal manifestations are evident or not[67]. The pathogenesis of stroke in CD youth may involve vitamin B12 deficiency[68] and possibly hyperhomocysteinemia, which may be secondary to folic acid deficiency[69], cerebral arterial vasculopathy, and antiphospholipid syndrome, a secondary autoimmune disorder[70-72]. Children with recurrent acute ischemic stroke should be screened for CD[73]. Because CD is a potentially treatable cause of cerebral vasculopathy and stroke[74], serology-specifically anti TTG antibodies should be included in the evaluation for cryptogenic stroke in childhood, even in the absence of typical gastrointestinal symptoms[72].

Vascular - hemorrhage [# = 10, median year = 2007 (1997-2012)]

When unresponsive CD is treated with corticosteroids and immunosuppression therapy, it can be complicated by the presence of small intestinal lymphoma, and result in hemorrhage[75,76]. During hemorrhage, coagulopathy can occur, which is attributable to vitamin K deficiency associated with malabsorption of multiple fat soluble vitamins in these patients[75]. The immune response to CD, triggered by gluten, can lead to deposition of circulating immune complexes on the membrane of alveolar capillaries, resulting in pulmonary hemosiderosis[77]. Lane-Hamilton syndrome refers to the co-occurrence of idiopathic pulmonary hemosiderosis and CD[78]. Idiopathic pulmonary hemosiderosis is severe and potentially fatal, and is characterized by recurrent episodes of alveolar hemorrhage, hemoptysis, and anemia, and can share a common immune pathway with CD[79]. Left untreated, it can lead to poor prognosis, with progression to pulmonary fibrosis and chronic respiratory limitation[80]. In patients with diffuse alveolar hemorrhage, even in the absence of gastrointestinal symptoms, screening for CD should be done using anti-transglutaminase antibodies[79,81]. If CD is found, the GFD helps control symptoms, enables a reduction of immunosuppressive treatment, and improves clinical course[79]. Improvement of the co-occurrence of CD and pulmonary hemosiderosis over a period of months is found when patients are placed on the GFD[82,83]. Thus patients with pulmonary hemosiderosis should always be screened for CD[80,82]. Patients with hereditary hemorrhagic telangiectasia with unexplained iron malabsorption should also be screened for CD[84].

Vascular - haemodynamics [# = 4, median year = 1998 (1993-2005)]

Alteration of blood flow is an important issue. The pathophysiological changes in the small bowel mucosa during the active phase of CD can induce haemodynamic changes[85] including an abnormal splanchnic circulation[86], and splenic vein obstruction may be present[47]. The postprandial mesenteric blood flow can be significantly increased and delayed in time[86]. A hyperdynamic mesenteric circulation and higher peak systolic velocity of the superior mesenteric artery is often manifested in untreated CD patients as compared with healthy controls and treated celiac patients[85,87]. Treatment with the GFD can improve haemodynamics[85,87].

Vascular - other [# = 5, median year = 2004 (1993-2013)]

Several other vascular maladies have been noted to occur in conjunction with CD. The combination of CD, epilepsy, and cerebral calcification is a rare condition known as CEC syndrome[88]. Folate malabsorption is a suggested mechanism, because cerebral calcification can be seen in other conditions related to folate deficiency[88]. Membranous obstruction of the inferior vena cava can also occur[89]. In patients with hyperhomocysteinaemia and sub-clinical CD, endothelial dysfunction is associated with increased systemic vascular resistance that can lead to a reversible form of hypertension[90]. CD adults tend to have a lower prevalence of hypertension and hypercholesterolaemia as compared with the general population[91]. However in patients with hypertension, CD, and hyperhomocysteinaemia (via malabsorption of essential cofactors), CD treatment can improve blood pressure control[90]. Covert hemoptysis may be responsible for disproportionately severe anemia in CD patients[92].

Heart - pericardial effusion [# = 4, median year = 2008 (2000-2014)]

The heart itself can be greatly affected in CD patients. Echocardiography has been used to show that there is a higher incidence of pericardial effusion in CD[93]. In adults, this phenomenon can be asymptomatic[94]. The predisposing factors for pericardial effusion include vessel dysfunction in the presence of high antibody titer, selenium deficiency, and viral infection due to reduced immunological competence, in conjunction with a diminished ability to eliminate toxic free radicals[93,95]. After onset of the GFD and with iron supplement, pericardial effusion, along with peripheral edema and fatigue, decreases[94,96]. Presence of left ventricle dilation, suggesting an initial phase of heart damage, is reversible on the GFD[96]. CD children may also have pericardial fluid, and show no difference compared to those lacking effusion with respect to ECG, chest X-ray, blood cell count, serum enzymes, serum protein, and iron levels[95]. Pericardial effusion is reversible in children when they are treated with a GFD[95,96]. Thus pediatric cardiologists should be alerted to the possibility that mild left ventricular enlargement can be caused by CD[96].

Heart - Myocarditis [# = 6, median year = 2004 (2002-2012)]

Autoimmune myocarditis may be a complication of CD[97]. Biopsy-proven granulocytic myocarditis of unknown etiology can be found in the setting of silent CD[98]. Progressive heart failure may accompany viral myocarditis in untreated CD; patient condition can improve following standard heart failure treatment and GFD[99]. A strong fluorescence around heart muscle fibers has been noted in untreated CD patients but not in patients on the diet or in controls[100]. This suggests that an autoimmune process toward antigenic components of the myocardium can occur in untreated CD, and lead to cardiac tissue injury, resulting in myocarditis[101]. In these patients, immunosuppression and GFD are often effective therapeutic options[101]. It is thus highly important to screen for CD in patients with these conditions to avoid progression and clinical deterioration[102]. It has been found that the CD prevalence in children with myocarditis is greater than in children without myocarditis[102], who should therefore also receive CD screening.

Heart - cardiomyopathy [# = 33, median year = 2010 (1986-2016)]

Cardiomyopathy associated with CD is a serious and potentially lethal condition which requires a multidisciplinary approach involving both a gastroenterologist and a cardiologist[103-106]. There is a higher prevalence of CD in patients with dilated cardiomyopathy[107-109], idiopathic cardiomyopathy[110-113] and ischaemic or valvular cardiomyopathy[110]. There is also a higher prevalence of CD in the relatives of patients with sporadic and inherited dilated cardiomyopathy[114]. Severely dilated left ventricle, concomitant left ventricular dysfunction, very low ejection fraction, pulmonary hemosiderosis, heart block, and/or heart failure have been reported in cardiomyopathy patients with CD[112,115-120]. Severe progressive dilated cardiomyopathy, requiring heart transplantation, can occur[121]. Dilated cardiomyopathy in CD may be accompanied by congestive heart failure and is also becoming increasingly recognized in the pediatric population[122,123]. These children may also present with acute onset congestive heart failure, as well as severe left ventricular systolic dysfunction[123]. Upper limb venous thrombosis and recurrent haemoptysis secondary to pulmonary haemosiderosis may be present[123]. Cirrhotic cardiomyopathy without gastrointestinal symptoms has also been found in pediatric patients[124].

Although a serious condition, the precise cause-and-effect relationship between CD and cardiomyopathy when they occur in tandem is currently unknown[125]. Dilated cardiomyopathy may evolve due to carnitine deficiency[126,127], which is related to CD, but may also develop after onset of the GFD, particularly in patients lacking carnitine supplementation[126]. Idiopathic dilated cardiomyopathy may have an autoimmune mechanism[110,128]. The tTG-positive serology in relatives with echocardiographic abnormalities suggests that immune-mediated mechanisms are at work in subsets of these patients and their families[106]. In individuals with idiopathic congestive cardiomyopathy and CD, ultrastructural and electrophoretic examination of myocardial samples shows a selective loss of actin, and electron microscopy reveals characteristic alterations of enterocyte microvilli[129]. Hence there can be an involvement of the microfilament system in both the myocardial sarcomeres and the enterocytes of these patients[129]. Ischemic cardiomyopathy can occur due to an accelerated atherosclerosis when chronic inflammation is present in CD[130].

Compliance with a GFD is mandatory if patients are to avoid progression of their cardiomyopathy[105,131]. The GFD has been shown to have a beneficial effect on cardiac performance in CD patients with dilated cardiomyopathy[132]. After start of the GFD, abnormal left ventricular dimensions, and diminished cardiac function, including decreased ejection fraction, can improve markedly and may even be completely reversible[103,108,118,128,133]. After two years on a GFD, patients presenting with dilated cardiomyopathy associated with CD show progressive increase in mean serum carnitine levels as compared to values observed prior to the diet[127]. Children with CD and dilated cardiomyopathy also have improved cardiac function once adherent to the GFD[109]. In CD patients on the GFD, there is no association with later onset of myocarditis, cardiomyopathy or pericarditis[134].

Screening for CD in patients with dilated cardiomyopathy, pulmonary haemosiderosis, and iron deficiency anemia in the absence of known etiology is advisable regardless of the intestinal symptoms[105,108,116,123,133]. Serologic tests for IgA-EmA and tissue transglutaminase antibodies should be used to screen for CD[106]. Co-morbidities including iron-deficiency anemia in patients with dilated cardiomyopathy should arouse suspicion of CD[117]. All patients diagnosed with cardiomyopathy and CD should be offered an endomyocardial biopsy for better histological and diagnostic definition[128]. It is beneficial to assess CD in children with dilated cardiomyopathy in the absence of known etiologies[104,135].

Heart - infarction [# = 5, median year = 2009 (2008-2015)]

Acute myocardial infarction with ST-elevation and spontaneous coronary artery dissection can occur in young patients with CD[3,136]. However, chronic hypocalcemia in untreated CD patients due to poor absorption of minerals can result in electrocardiographic changes that mimic acute myocardial infarction[120]. In CD, there is a higher all-cause mortality one year post-myocardial infarction as compared with the general population[20]. Mesenteric infarction has also occurred as a consequence of CD, and clinicians should be aware of this possibility[137].

Heart - electromechanical functioning [# = 7, median year = 2014 (2008-2016)]

Measurement of electromechanical parameters is beneficial to determine the degree of cardiac involvement in CD[138]. Atrial conduction delays are significantly higher in untreated CD as compared with healthy individuals, and may lead to atrial fibrillation[139]. Measurement of atrial electromechanical delay parameters might therefore be useful to predict atrial fibrillation risk[139]. Statistically significant differences in left ventricular function as assessed by echocardiography imaging are found in CD patients vs controls[140]. Patients with CD can have impaired diastolic and systolic function as measured by tissue Doppler echocardiography[141]. Mitral valve prolapse[142] and subclinical myocardial dysfunction of both ventricles[143] can be present in both the pediatric and adult CD population. In children, significantly lower contractility indices and higher left ventricular dimensions are evident as compared with controls[144]. On the GFD, valve regurgitations resolve, and echocardiographic parameters significantly improve[144].

Heart - ischemic heart disease [# = 11, median year = 2014 (2004-2016)]

There is an increased risk of ischemic heart disease and higher cardiovascular mortality in CD[145,146] despite the lack of traditional risk factors[26,147] including blood pressure, body mass index, serum cholesterol, lipids, exercise, and smoking[4,148]. First-degree relatives of CD patients are also at an increased risk of ischemic heart disease, but the excess risk is slight[149]. CD and ischemic heart disease may share a common underlying link, rather than a cause-and-effect relationship[18,150]. The underlying association between CD and ischemic heart disease may be chronic inflammation, a major risk factor in the general population; however, potential confounders may also be involved[18,146,148]. After onset of the GFD, persistent villous atrophy detected during follow-up biopsy was not associated with increased risk of ischemic heart disease[151,152].

Rhythm disturbances [# = 8, median year = 2014 (1989-2016)]

Compared to controls, untreated CD patients have increased P-wave dispersion and higher interatrial, intra-left atrial, and intra-right atrial conduction delay[153]. Tp-e interval, Tp-e/QT and Tp-e/QTc ratios are also increased in CD[154]. There is a higher prevalence of atrial fibrillation among CD patients[153,155]. Atrial fibrillation, when it occurs, is associated with an increased risk of ischaemic stroke and heart failure[156]. The chronic inflammation that can occur in untreated CD is a recognized risk factor for atrial fibrillation[155,156]. CD patients have slower atrial electrical conduction, which may also increase the risk of atrial fibrillation[153]. However, persistent villous atrophy on follow-up biopsy was not associated with any increased risk of atrial fibrillation[151,152]. It has been reported that CD patients with pulmonary hemosiderosis can develop infranodal heart block, necessitating implantation of a pacemaker[77,157]. These patients may lack digestive manifestations but have iron deficiency and vitamin deficiency anemia[77]. Rhythm alterations in CD can thus result from other pathogenic mechanisms including electrolyte disturbances caused by malabsorption, which can normalize on the GFD[77]. Patients with rhythm disturbances and chronic anemia of unclear origin should therefore be tested for CD[77].

Heart - congenital heart defect [# = 4, median year = 2014 (1982-2016)]

CD patients are likely to more commonly have atrial septal defect as compared to controls[158]. Screening for CD in children with congenital heart defect is recommended, since serum TTG IgA levels are significantly higher in patients with congenital heart defect vs control children[159]. Down syndrome patients with congenital heart defect have higher CD prevalence as compared to patients without congenital heart defect, and CD prevalence in Down syndrome patients is higher than in controls[160]. In children with congenital heart disease and CD, growth improves on a GFD[161].

Heart - other [# = 6, median year = 2012 (2004-2016)]

Chronic hypocalcemia, which may occur in untreated CD due to malabsorption, has been associated with reversible cardiac dysfunction[120]. Untreated CD children tend to show an imbalance of cardiac sympathetic and parasympathetic activity due to enhanced sympathetic tone[162]. This imbalance is still detected after a six months period of GFD[162]. This suggests the presence of a subclinical autonomic nervous system dysfunction[162]. There is a higher prevalence of CD in patients with Postural Orthostatic Tachycardia Syndrome (POTS)[163]; thus these patients should also be screened for CD[164]. Left ventricular hypertrabeculation/noncompaction may be associated with CD[165]. Subclinical systolic dysfunction of the left ventricle may be present in CD children[166].

Cardiovascular disease risk factors [# = 17, median year = 2013 (2007-2017)]

Cardiovascular disease (CVD) as a whole has many etiologies and is the leading cause of death in developed countries[167,168]. There is a modestly increased risk of CVD in CD patients[63]. Both male and female CD patients may have higher estimated risk for CVD as compared to controls[169,170]. However, CVD risk factors conferred by CD have not been well-defined[171]. This has led to conflicting evidence as to whether CD patients actually have increased baseline risk[172]. CD patients are susceptible to increased platelet activation and increased mean platelet volume and RDW values, factors that contribute to increased risk[173,174]. Using the Framingham Heart Study (FRS) 10-year general CVD risk score, lower values were found among CD patients as compared with controls, which may be due to a lesser body mass index and reduced tobacco use among CD patients[171]. Risk factors other than those measured by the FRS may be observed as increased risk of CVD in CD patients[171]. There can also be a positive association between CD and CVD risk due to ascertainment bias[175]. In CD children, risk factors can be frequently observed as compared with healthy subjects[18]. Overall, certain CVD risk factors have been found to be higher in CD youth as compared with the general population, although neither blood pressure nor overweight and obesity rates were increased[176]. Youth with type 1 diabetes and CD had lower high density lipoprotein (HDL) cholesterol, increasing CVD risk, as compared with non CD patients[177].

The lack of a uniform set of risk factors can influence whether CVD risk is affected by a GFD[172]. In actuality, both risk and protective factors for CVD are likely to be present in CD, at baseline and also on a GFD[172]. Modifiable risk factors for CVD can include body mass index and cholesterol, which have been shown to increase on the GFD[168]. In CD individuals with type 1 diabetes on a GFD, improvement in HDL-cholesterol, and a lower resting heart rate, has been demonstrated as compared with those CD patients without diabetes[178]. On a GFD, the lipid profile of CD patients can also improve[17]. At one year on a GFD, waist circumference may increase, but without significant rise in total or LDL cholesterol[173,174]. The GFD should therefore ideally go beyond gluten exclusion and include body weight control and high quality nutrients[172]. A relatively high proportion of CD children on the GFD had one or more CVD risk factors[179]. The most common CVD risk factors are high fasting triglycerides, elevated blood pressure, and high LDL cholesterol concentrations[179]. Insulin resistance is also found, underscoring the need for CVD screening and dietary counseling targeting the pediatric CD population[179]. Screening for CD and monitoring of HDL cholesterol is recommended in youth with type 1 diabetes[177]. CVD risk factors also include metabolic disorders caused by malabsorption in pediatric CD patients[180]. Hence timely correction of water and electrolyte imbalance, and administration of cardiometabolic therapy, is necessary[180].

CONCLUSION

Published studies pertaining to the connection between cardiovascular conditions and CD began in the late 1960’s, consisting of a few studies each year, and was followed by a substantial increase beginning about the year 2000. Many of the published studies are either articles (including cohort and case control studies) or case studies consisting of one to three patients. Often, as might be expected, a number of case studies appeared in the literature prior to the cohort studies. Based on the evidence presented in these papers, it is apparent that cardiovascular involvement in CD is a real phenomenon and that there are many manifestations, owing to the multifaceted, systemic physiological changes that can occur in CD. A number of the cardiovascular issues that can occur in untreated CD patients, will resolve on a GFD, often in conjunction with healing of the small intestinal villi. Cardiomyopathy is the most frequently documented cardiovascular condition observed in conjunction with CD, and seems to mostly or completely resolve with appropriate treatment, including a GFD. However, if CD is left unrecognized until a late stage, damage done to the heart may not be entirely reversible. Similarly, to the present time there has been substantial documentation of a number of other cardiovascular conditions found in conjunction with untreated CD including thrombosis and thromboembolism, ischemic heart disease, stroke, and arrhythmia. There has also been significant investigation of CD and risk of cardiovascular disease. On this topic, a current problem is that there is no uniform set of cardiovascular risk factors used for analysis. Future studies should settle the question of how to best treat these co-occurring conditions, and to determine if other cardiovascular manifestations of CD are common phenomena.

Footnotes

Conflict-of-interest statement: The authors have no conflicts of interest.

Manuscript source: Invited manuscript

Specialty type: Cardiac and cardiovascular systems

Country of origin: United States

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

Peer-review started: February 22, 2017

First decision: May 8, 2017

Article in press: July 3, 2017

P- Reviewer: Balaban YH S- Editor: Qi Y L- Editor: A E- Editor: Lu YJ

References

1. LodhaAHaranMHollanderGFrankelRShaniJCeliac disease associated with dilated cardiomyopathySouth Med J200910210521054[PubMed][Google Scholar]
2. RybakACukrowskaBSochaJSochaPLong term follow up of celiac disease-is atherosclerosis a problem?Nutrients2014627182729[PubMed][Google Scholar]
3. Bayar N, Çağırcı G, Üreyen ÇM, Kuş G, Küçükseymen S, Arslan ŞThe relationship between spontaneous multi-vessel coronary artery dissection and celiac diseaseKorean Circ J201545242244[PubMed][Google Scholar]
4. WangIHopperICeliac disease and drug absorption: implications for cardiovascular therapeuticsCardiovasc Ther201432253256[PubMed][Google Scholar]
5. CiaccioEJBhagatGLewisSKGreenPHTrends in celiac disease researchComput Biol Med201565369378[PubMed][Google Scholar]
6. CiaccioEJBhagatGLewisSKGreenPHTrends in gluten research and its relationship to autoimmune and allergic diseasesInformat Med Unlocked20163714[Google Scholar]
7. CiaccioEJBivianoABIyerVGaranHTrends in quantitative methods used for atrial fibrillation and ventricular tachycardia analysesInformat Med Unlocked201761227[Google Scholar]
8. SariCErtemAGSariSEfeTHKelesTDurmazTErtemSBozkurtEImpaired aortic function in patients with coeliac diseaseKardiol Pol20157311081113[PubMed][Google Scholar]
9. KorkmazHSozenMKebapcilarLIncreased arterial stiffness and its relationship with inflammation, insulin, and insulin resistance in celiac diseaseEur J Gastroenterol Hepatol20152711931199[PubMed][Google Scholar]
10. Bayar N, Çekin AH, Arslan Ş, Çağırcı G, Küçükseymen S, Çay S, Harmandar FA, Yeşil BAssessment of Aortic Elasticity in Patients with Celiac DiseaseKorean Circ J201646239245[PubMed][Google Scholar]
11. JansenHWillenborgCSchlesingerSFerrarioPGKönigIRErdmannJSamaniNJLiebWSchunkertHGenetic variants associated with celiac disease and the risk for coronary artery diseaseMol Genet Genomics201529019111917[PubMed][Google Scholar]
12. AltabasKCrneNFranjićBDPavlovićDJosipovićJ[Peritoneal dialysis in a patient with right hemiparesis, lupus nephritis, significant insufficiency of arteries of aortic arch and celiac disease: case report]Acta Med Croatica201266 Suppl 27275[PubMed][Google Scholar]
13. HeikkiläKKoskinenOAAgarwalATikkinenKAMäkiMKaukinenKAssociations of coeliac disease with coronary heart disease and cerebrovascular disease: A systematic review and meta-analysisNutr Metab Cardiovasc Dis201525816831[PubMed][Google Scholar]
14. De MarchiSChiarioniGPriorMArosioECommentary: coeliac disease and atherosclerosis--hand in hand? Authors’ replyAliment Pharmacol Ther201338550551[PubMed][Google Scholar]
15. PitoccoDZaccardiFMartiniFGiubilatoSLiuzzoGCreaFGhirlandaGThe cardiovascular relevance of celiac diseaseDiabetes Care201235e20[PubMed][Google Scholar]
16. PitoccoDGiubilatoSMartiniFZaccardiFPazzanoVMantoACammarotaGDi StasioEPedicinoDLiuzzoGCombined atherogenic effects of celiac disease and type 1 diabetes mellitusAtherosclerosis2011217531535[PubMed][Google Scholar]
17. LeedsJSHopperADHadjivassiliouMTesfayeSSandersDSHigh prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac diseaseDiabetes Care20113421582163[PubMed][Google Scholar]
18. MormileRCeliac Disease and Ischemic Heart Disease: What is the Link?J Clin Cell Immunol20134: 2[Google Scholar]
19. MormileRCeliac disease and atherosclerosis: An immunologic puzzle to be solved?Immunol Lett20161807576[PubMed][Google Scholar]
20. RigoniADe MarchiSPriorMChiarioniGArosioE100 young adults with celiac disease may be at increased risk of early atherosclerosisNutrition, Metabolism Cardiovascular Dis200818S58[Google Scholar]
21. De MarchiSChiarioniGPriorMArosioEYoung adults with coeliac disease may be at increased risk of early atherosclerosisAliment Pharmacol Ther201338162169[PubMed][Google Scholar]
22. MartiniFPitoccoDZaccardiFGiubilatoSPallanoVMantoACammarotaGLiuzzoGCreaFGhirlandaGEarly Detection of cardiovascular disease in patients with associated type 1 diabetes mellitus and celiac disease. 1701 N Beauregard St, Alexandria, VA 22311-17172011USAAmer Diabetes Assoc
23. ValituttiFTrovatoCMBarbatoMCucchiaraSLetter: Atherosclerosis and coeliac disease – Another feature of the changing paradigm?Aliment Pharmacol Therap201338559[PubMed][Google Scholar]
24. EmilssonLCarlssonRJamesSLudvigssonJFLetter: Coeliac disease and ischaemic heart disease - a true additional risk factor? Authors’ replyAliment Pharmacol Therap2013371118[Google Scholar]
25. AguilarECSoaresFLSantosLCCapettiniLSTeixeiraLGLemosVSAlvarez-LeiteJISUN-LB037: Gluten-free diet reduces cardiovascular risk factors and atherosclerosis development in APOE KO miceClin Nutr201534S248[Google Scholar]
26. DemirAMKuloğluZYamanAFitözSNergizoğluGKansuACarotid intima-media thickness and arterial stiffness as early markers of atherosclerosis in pediatric celiac diseaseTurk J Pediatr201658172179[PubMed][Google Scholar]
27. BianchiPIBiagiFBorsottiEMarcheseAVattiatoCFerrettiFBalduzziDTrottaLSchiepattiACorazzaGRP. 05.13 Peripheral artery disease in coeliac diseaseDig Liver Dis201345S123[Google Scholar]
28. ZaniniBMazzonciniELanzarottoFRicciCCesanaBMVillanacciVLanziniAImpact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patientsDig Liver Dis201345810815[PubMed][Google Scholar]
29. MyrskyECajaSSimon-VecseiZKorponay-SzaboIRNadaluttiCCollighanRMongeotAGriffinMMäkiMKaukinenKCeliac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoACell Mol Life Sci20096633753385[PubMed][Google Scholar]
30. MyrskyESyrjänenMKorponay-SzaboIRMäkiMKaukinenKLindforsKAltered small-bowel mucosal vascular network in untreated coeliac diseaseScand J Gastroenterol200944162167[PubMed][Google Scholar]
31. MyrskyESyrjänenMKaukinenKKorponay-SzaboIMakiMLindforsKCeliac disease IGA class autoantibodies inhibit the recruitment of vascular smooth muscle cells to capillary wallsJ Pediatr Gastroenterol Nutr200642E1[Google Scholar]
32. MyrskyEKaukinenKSyrjänenMKorponay-SzabóIRMäkiMLindforsKCoeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesisClin Exp Immunol2008152111119[PubMed][Google Scholar]
33. KalliokoskiSSulicAMKorponay-SzabóIRSzondyZFriasRPerezMAMartuccielloSRoivainenAPelliniemiLJEspositoCCeliac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell DynamicsPLoS One20138e65887[PubMed][Google Scholar]
34. Castellanos-RubioACajaSIrastorzaIFernandez-JimenezNPlaza-IzurietaLVitoriaJCMakiMLindforsKBilbaoJRAngiogenesis-related gene expression analysis in celiac diseaseAutoimmunity201245264270[PubMed][Google Scholar]
35. ShinerMMucosal vascular changes in coeliac disease and in idiopathic steatorrhoeaMicron19702718[Google Scholar]
36. BoucelmaMSaadiMBoukraraHBensalahDHakemDBerrahA[Association of celiac disease and cerebral venous thrombosis: report of two cases]J Mal Vasc2013384751[PubMed][Google Scholar]
37. BeyroutiRMansourMKacemADerbaliHMrissaRRecurrent cerebral venous thrombosis revealing celiac disease: an exceptional case reportActa Neurol Belg2017117341343[PubMed][Google Scholar]
38. PoulinWGaertnerSCordeanuEMMireaCAndrèsEStephanDStroke revealing celiac disease associated with multiple arterial thrombotic locationsPresse Med201544537538[PubMed][Google Scholar]
39. ÇelikGÇiledağAKeskinOEnsariAKarabörkAKayaASarcoidosis, Celiac disease and deep venous thrombosis: A rare associationBalkan Med J201128450452[Google Scholar]
40. BahloulMChaariAKhlaf-BouazizNKallelHChaariLBen HamidaCChellyHRekikNBouazizM[Celiac disease, cerebral venous thrombosis and protein S deficiency, a fortuitous association?]J Mal Vasc200530228230[PubMed][Google Scholar]
41. KallelLMatriSKarouiSFekihMBoubakerJFilaliADeep venous thrombosis related to protein S deficiency revealing celiac diseaseAm J Gastroenterol2009104256257[PubMed][Google Scholar]
42. BaryshnikovENKrumsLMVorob’evaNNParfenovAI[Lower extremity deep vein thrombosis associated with gluten-sensitivity celiac disease]Ter Arkh2010825254[Google Scholar]
43. LeeESPulidoJSNonischemic central retinal vein occlusion associated with celiac diseaseMayo Clin Proc200580157[PubMed][Google Scholar]
44. JohannesdottirSAErichsenRHorváth-PuhóESchmidtMSørensenHTCoeliac disease and risk of venous thromboembolism: a nationwide population-based case-control studyBr J Haematol2012157499501[PubMed][Google Scholar]
45. DoğanMPekerEAkbayramSBektasMSBasaranogluMCesurYCaksenHCerebral venous sinus thrombosis in 2 children with celiac diseaseClin Appl Thromb Hemost201117466469[PubMed][Google Scholar]
46. GroverPJJayaramRMadderHManagement of cerebral venous thrombosis in a patient with Lane-Hamilton syndrome and coeliac disease, epilepsy and cerebral calcification syndromeBr J Neurosurg201024684685[PubMed][Google Scholar]
47. GhoshalUCSaraswatVAYachhaSKAssociation of splenic vein obstruction and coeliac disease in an Indian patientJ Hepatol199523358[Google Scholar]
48. BeyanEPamukcuogluMBeyanCDeep vein thrombosis associated with celiac diseaseBratisl Lek Listy2009110263264[PubMed][Google Scholar]
49. GriggAPDeep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemiaAust N Z J Med199929566567[PubMed][Google Scholar]
50. CasellaGBaldiniVPeregoDBrambillsMFraterrigoRTA rare association between inflammatory bowel disease (IBD), coeliac disease, membranous glomerulonephritis and leg venous thrombosis associated to heterozygosis for V Leiden factorDige Liver Dis200032A44[Google Scholar]
51. CasellaGPeregoDBaldiniVMontiCCrippaSBudaCAA rare association between ulcerative colitis (UC), celiac disease (CD), membranous glomerulonephritis, leg venous thrombosis, and heterozygosity for factor V LeidenJ Gastroenterol200237761762[PubMed][Google Scholar]
52. HidaMErreimiNEttairSMouaneNBouchtaFAssociated celiac disease and venous thrombosisArch Pediatr20007215216[PubMed][Google Scholar]
53. MezalekZTHabibaBAHichamHHoudaBMounaMMohamedAMohamedAC0396 Venous thrombosis revealing celiac disease. Three casesThrom Res2012130S154S155[Google Scholar]
54. Kremer HovingaJABaerlocherGWuilleminWASolenthalerM[Deep venous thrombosis of the leg in acquired thrombophilia--hyperhomocysteinemia as a sequela of undetected celiac disease]Ther Umsch199956519522[PubMed][Google Scholar]
55. LudvigssonJFWelanderALassilaREkbomAMontgomerySMRisk of thromboembolism in 14,000 individuals with coeliac diseaseBr J Haematol2007139121127[PubMed][Google Scholar]
56. KarouiSSfarSKallelMBoubakerJMakniSFilaliA[Antiphospholipid syndrome revealed by portal vein thrombosis in a patient with celiac disease]Rev Med Interne200425471473[PubMed][Google Scholar]
57. ZenjariTBoruchowiczADesreumauxPLaberenneECortotAColombelJFAssociation of coeliac disease and portal venous thrombosisGastroenterol Clin Biol199519953954[PubMed][Google Scholar]
58. AzzamNAAl AshgarHDababoMAl KahtaniNShahidMMesentric vein thrombosis as a presentation of subclinical celiac diseaseAnn Saudi Med200626471473[PubMed][Google Scholar]
59. KhannaSChaudharyDKumarPMazumdarSOccult celiac disease presenting as splenic vein thrombosisIndian J Gastroenterol2008273839[PubMed][Google Scholar]
60. UngprasertPWijarnpreechaKTanratanaPRisk of venous thromboembolism in patients with celiac disease: A systematic review and meta-analysisJ Gastroenterol Hepatol20163112401245[PubMed][Google Scholar]
61. GabrielliMSantoliquidoASantarelliLFiniLAndrisaniMCPolaPGasbarriniGGasbarriniA6 P Venous thromboembolism, hyperhomocysteinemia and silent coeliac disease: A case reportDigestive and Liver Disease200234A27[Google Scholar]
62. ZoubeidiHBen SalemTBen GhorbelIHoumanMHCentral retinal vein occlusion revealing celiac diseaseEur J Case Reports Int Med20163[Google Scholar]
63. EmilssonLLebwohlBSundströmJLudvigssonJFCardiovascular disease in patients with coeliac disease: A systematic review and meta-analysisDig Liver Dis201547847852[PubMed][Google Scholar]
64. LudvigssonJFWestJCardTAppelrosPRisk of stroke in 28,000 patients with celiac disease: A nationwide cohort study in SwedenJ Stroke Cerebrovascular Dis201221860867[Google Scholar]
65. OzgeAKarakelleAKaleağasiHCeliac disease associated with recurrent stroke: a coincidence or cerebral vasculitis?Eur J Neurol20018373374[PubMed][Google Scholar]
66. MillichapJGCeliac Disease and StrokePediatr Neurol Briefs20041864[Google Scholar]
67. El MoutawakilBChourkaniNSibaiMMoutaouakilFRafaiMBourezguiMSlassiI[Celiac disease and ischemic stroke]Rev Neurol (Paris)2009165962966[PubMed][Google Scholar]
68. RachidBZouhayrSChtaouNMessouakOBelahsenF[Ischemic stroke revealing celiac disease]Pan Afr Med J201052[PubMed][Google Scholar]
69. GefelDDonchevaMBen-ValidEel Wahab-DarausheALugassyGSelaBARecurrent stroke in a young patient with celiac disease and hyperhomocysteinemiaIsr Med Assoc J20024222223[PubMed][Google Scholar]
70. AjelloAVitulloGStroke and coeliac disease: a new face for an old ladyItalian J Pediatr200632259[Google Scholar]
71. AudiaSDuchêneCSamsonMMullerGBielefeldPRicolfiFGiroudMBesancenotJF[Stroke in young adults with celiac disease]Rev Med Interne200829228231[PubMed][Google Scholar]
72. GoodwinFCBeattieRMMillarJKirkhamFJCeliac disease and childhood strokePediatr Neurol200431139142[PubMed][Google Scholar]
73. BalciOSezerTThe Prevalence of Celiac Disease in Children With Arterial Ischemic StrokeJ Pediatr Hematol Oncol2017394649[PubMed][Google Scholar]
74. SlimaniNHakemDMansouriBBerrahAIschemic stroke revealing a celiac disease: A case report and review of the literatureJ Neurol Sci2013333e248[Google Scholar]
75. ChenCSCumblerEUTrieblingATCoagulopathy due to celiac disease presenting as intramuscular hemorrhageJ Gen Intern Med20072216081612[PubMed][Google Scholar]
76. GheorgheLPopescuIGheorgheCAposteanuGPopescuCOproiuAFatal intestinal hemorrhage complicating ileal lymphoma after cyclosporine for unresponsive celiac diseaseHepato-Gastroenterology19964413421345[Google Scholar]
77. Callejas RubioJLOrtegoNDíez-RuizAGuilarteJde la Higuera-TorresJCeliac disease presenting as chronic anemia associated with heart blockAm J Gastroenterol19989313911392[PubMed][Google Scholar]
78. SethiGRSinghalKKPuriASMantanMBenefit of gluten-free diet in idiopathic pulmonary hemosiderosis in association with celiac diseasePediatr Pulmonol201146302305[PubMed][Google Scholar]
79. TestaMEMaffeyAColomAAgüeroLRogéIAndrewarthaMSTeperA[Pulmonary hemorrhage associated with celiac disease]Arch Argent Pediatr2012110e72e76[PubMed][Google Scholar]
80. SantosJWMello NetoABMarchioriRCMichelGTFagundesALTagliariLGCancianTPulmonary hemosiderosis associated with celiac disease: improvement after a gluten-free dietJ Bras Pneumol201238412414[PubMed][Google Scholar]
81. CottinVClériciGFabienNRoussetHCordierJFCeliac disease revealed by diffuse alveolar hemorrhage and heart blockRespirat Med Extra200628991[Google Scholar]
82. AbuidMKopecSEFisherKFraireAAlveolar hemorrhage and celiac disease: A case of Lane-Hamilton SyndromeAm J Respirat Critical Care Med2010181A4000[Google Scholar]
83. AydoganMGundoganAUcarETasciCGumusSPolatZDenizOTozkoparanEOzkanMBilgicHCoexistance of idiopathic pulmonary hemosiderosis and celiac disease: Complete remission with gluten free dietEur Respiratory J201240Suppl 56P3684[Google Scholar]
84. LapecorellaMNapolitanoMMarianiGHereditary hemorrhagic teleangectasia with celiac disease and atrial fibrillationEur J Intern Med200718349[PubMed][Google Scholar]
85. ErtemDTüneyDBalogluHPehlivanogluESuperior mesenteric artery blood flow in children with celiac diseaseJ Pediatr Gastroenterol Nutr199826140145[PubMed][Google Scholar]
86. AlvarezDVazquezHBaiJCMastaiRFloresDBoerrLSuperior mesenteric artery blood flow in celiac diseaseDig Dis Sci19933811751182[PubMed][Google Scholar]
87. AlAttarWAMajeedSEShubbarAHSuperior mesenteric artery blood flow in celiac disease. Estimation with Doppler ultrasound”IJGE200553843[Google Scholar]
88. ByeAMAndermannFRobitailleYOliverMBohaneTAndermannECortical vascular abnormalities in the syndrome of celiac disease, epilepsy, bilateral occipital calcifications, and folate deficiencyAnn Neurol199334399403[PubMed][Google Scholar]
89. MartínezFBerenguerMPrietoMMontesHRayónMBerenguerJBudd-Chiari syndrome caused by membranous obstruction of the inferior vena cava associated with coeliac diseaseDig Liver Dis200436157162[PubMed][Google Scholar]
90. LimPOTzemosNFarquharsonCAAndersonJEDeeganPMacWalterRSStruthersADMacDonaldTMReversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunctionJ Hum Hypertens200216411415[PubMed][Google Scholar]
91. WestJLoganRFCardTRSmithCHubbardRRisk of vascular disease in adults with diagnosed coeliac disease: a population-based studyAliment Pharmacol Ther2004207379[PubMed][Google Scholar]
92. SinghalKKJanmejaAKSodhiRPuniaRSHemoptysis in patients of celiac disease with disproportionately severe anemia: tip of the iceberg?Multidiscip Respir Med2013825[PubMed][Google Scholar]
93. AshrafiFDarakhshandehAHeidarpourMTavakoliTNajafianJPericardial effusion in celiac diseaseInt J Prev Med20145356359[PubMed][Google Scholar]
94. AshrafiFDarakhshandehAHeidarpourMTavakoliTNajafianJPericardial effusion in celiac disease: A case reportInt J Prevent Med20145356359[Google Scholar]
95. RiccabonaMRossipalE[Pericardial effusion in celiac disease--an incidental finding?]Wien Klin Wochenschr20001122731[PubMed][Google Scholar]
96. NennaRFerriMThanasiELupariaRVersacciPAnaclerioSBonamicoMP0444 The heart in coeliac disease children and adolescents. An ultrasonographic studyJ Pediatr Gastroenterol Nutr200439S224S225[Google Scholar]
97. Namendys SilvaSAPosadas CallejaJGDomínguez CheritG[Myocardial depression in a patient with celiac disease. A clinical case report and literature review]Rev Gastroenterol Mex2005706366[Google Scholar]
98. MazurkiewiczLBilinskaZTWitkowskiAWalczakEWagnerTGrzybowskiJBieganowskiAMichalakEWozniewiczBRuzylloW351 Unexpected granulocytic myocarditis detected with endomyocardial biopsy manifesting as severe heart failure with conduction disease in a young patient with silent celiac diseaseEur J Heart Failure2004389[Google Scholar]
99. MazurkiewiczLBilińskaZTWitkowskiAGrzybowskiJMichalakEBieganowskiAWalczakEWagnerTWoźniewiczBRuzyłłoW[Myocardial microabscesses detected by endomyocardial biopsy in a patient with dilated cardiomyopathy and celiac disease: a case report]Kardiol Pol200664733736[PubMed][Google Scholar]
100. Sategna-GuidettiCFrancoEMartiniSBobbioMBinding by serum IgA antibodies from patients with coeliac disease to monkey heart tissueScand J Gastroenterol200439540543[PubMed][Google Scholar]
101. FrustaciACuocoLChimentiCPieroniMFioravantiGGentiloniNMaseriAGasbarriniGCeliac disease associated with autoimmune myocarditisCirculation200210526112618[PubMed][Google Scholar]
102. MenezesTMMottaMECeliac disease prevalence in children and adolescents with myocarditis and dilated cardiomiopathyJ Pediatr (Rio J)201288439442[PubMed][Google Scholar]
103. GoelNKMcBaneRDKamathPSCardiomyopathy associated with celiac diseaseMayo Clin Proc200580674676[PubMed][Google Scholar]
104. BoskovicAKiticIProkicDStankovicICardiomyopathy associated with celiac disease in childhoodCase Rep Gastrointest Med20122012170760[PubMed][Google Scholar]
105. Mikolašević I, Zaninović-Jurjević T, Zaputović L, Mavrić Ž, Mulc S, Licul V, Štimac D, Tomulić V, Mijandrušić-Sinčić BCeliac disease (gluten-sensitive enteropathy) and dilated cardiomyopathyIn Kongres Hrvatskoga Kardiolokog Društva20127Suppl 16364[Google Scholar]
106. De BemRSDa Ro Sa UtiyamaSRNisiharaRMFortunatoJATondoJACarmesERSouzaRAPisaniJCAmaranteHMCeliac disease prevalence in Brazilian dilated cardiomyopathy patientsDig Dis Sci20065110161019[PubMed][Google Scholar]
107. NotTFaleschiniETommasiniARepettoAPasottiMBaldasVSpanoASblatteroDMarzariRCampanaCCeliac disease in patients with sporadic and inherited cardiomyopathies and in their relativesEur Heart J20032414551461[PubMed][Google Scholar]
108. CurioneMBarbatoMCuginiPAmatoSDa RosSDi BonaSAssociation of cardiomyopathy and celiac disease: an almost diffuse but still less know entity. A reviewArch Med Sci20084103107[Google Scholar]
109. GelfondDFasanoADilated cardiomyopathy and type I diabetes in a patient with celiac diseaseJ Pediatric Gastroenterol Nutr200643E43[Google Scholar]
110. VizzardiELanzarottoFCarabelleseNMoraABertolazziSBeniniFNodariSDei CasLLanziniALack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathiesScand J Clin Lab Invest200868692695[PubMed][Google Scholar]
111. EmilssonLAnderssonBElfströmPGreenPHLudvigssonJFRisk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac diseaseJ Am Heart Assoc20121e001594[PubMed][Google Scholar]
112. Winter Del RJLGabrielli NLGreigDInchausteGQuezadaFTorres MJCastro GP[Dilated cardiomyopathy in celiac disease: report of one case]Rev Med Chil200913714691473[PubMed][Google Scholar]
113. FonagerKSørensenHTNørgårdBThulstrupAMCardiomyopathy in Danish patients with coeliac diseaseLancet19993541561[Google Scholar]
114. Di LenardaAChiccoDMorettiMAndreaTValentinaBTarcisioNSinagraGPrevalence of organ-specific autoantibodies and coeliac disease in patients with sporadic and inherited dilated cardiomyopathy and their relativesJ Am College Cardiol20074960A60[Google Scholar]
115. NarulaNRawalPKumarRMRam ThapaBAssociation of celiac disease with cardiomyopathy and pulmonary hemosiderosisJ Trop Pediatr201056201203[PubMed][Google Scholar]
116. IşikaySYilmazKKilinçMCeliac disease with pulmonary haemosiderosis and cardiomyopathyBMJ Case Rep20122012[Google Scholar]
117. KhilnaniGCJainNTiwariPHaddaVSinghLA young man with hemoptysis: Rare association of idiopathic pulmonary hemosiderosis, celiac disease and dilated cardiomyopathyLung India2015327072[PubMed][Google Scholar]
118. McGrathSThomasAGorardDACardiomyopathy responsive to gluten withdrawal in a patient with coeliac diseaseBMJ Case Reports20162016bcr2015213301[Google Scholar]
119. OualiSChabrakSLarbiNKafsiN[Dilated cardiomyopathy and atrio-ventricular block in coeliac disease. Two case reports]Arch Mal Coeur Vaiss20069912521255[PubMed][Google Scholar]
120. MavroudisKAloumanisKStamatisPAntonakoudisGKifnidisKAntonakoudisCIrreversible end-stage heart failure in a young patient due to severe chronic hypocalcemia associated with primary hypoparathyroidism and celiac diseaseClin Cardiol201033E72E75[PubMed][Google Scholar]
121. BarrioJPCuraGRamalloGDiezMViglianoCAKatusHAMerelesDHeart transplantation in rapidly progressive end-stage heart failure associated with celiac diseaseBMJ Case Rep20112011bcr1220103624[Google Scholar]
122. SidhuSMFishelSCDunkerleyGRLindenbergBEnd-stage dilated cardiomyopathy in a 25-year-old presenting with symptoms of gluten enteropathySouthern Med J200497S13[Google Scholar]
123. PoddarBShavaUSrivastavaAKapoorASevere heart failure, dilated cardiomyopathy and pulmonary haemosiderosis in coeliac disease: report of two casesPaediatr Int Child Health201434142144[PubMed][Google Scholar]
124. RoumeliotisNHoskingMGuttmanOCeliac disease and cardiomyopathy in an adolescent with occult cirrhosisPaediatr Child Health201217437439[PubMed][Google Scholar]
125. LakhhdarRBen SlimaHDrissaMDrissaHFamilial dilated cardiomyopathy associated with celiac diseaseTunis Med201290181183[PubMed][Google Scholar]
126. UsluNDemirHKaragözTSaltik-TemizelINDilated cardiomyopathy in celiac disease: role of carnitine deficiencyActa Gastroenterol Belg201073530531[PubMed][Google Scholar]
127. CurioneMDaneseCViolaFDi BonaSAnastasiaACuginiPBarbatoMCarnitine deficiency in patients with coeliac disease and idiopathic dilated cardiomyopathyNutr Metab Cardiovasc Dis200515279283[PubMed][Google Scholar]
128. RomagnoliEBoldriniEPietrangeloAAssociation between celiac disease and idiopathic dilated cardiomyopathy: a case reportIntern Emerg Med20116125128[Google Scholar]
129. ChuaquiBGarridoJCasanegraPActin-deficient cardiomyopathy coexisting with celiac disease: a chance association?Pathol Res Pract1986181604614[PubMed][Google Scholar]
130. GhorbelIBHajjiRFekiNBSalemTBLamloumMHoumanMHTwo exceptional complications revealing celiac disease: ischemic cardiomyopathy and pellagraInt J Celiac Dis201533132[Google Scholar]
131. LernerAMatthiasTCeliac disease: Intestinal, heart and skin interconnectionsInt J Celiac Dis201532830[Google Scholar]
132. CurioneMBarbatoMViolaFFranciaPDe BiaseLCucchiaraSIdiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performanceDig Liver Dis200234866869[PubMed][Google Scholar]
133. GloverBMTreanorNJMcEneaneyDJA case of dilated cardiomyopathy associated with coeliac diseaseArchives Med Sci20073272[Google Scholar]
134. ElfströmPHamstenAMontgomerySMEkbomALudvigssonJFCardiomyopathy, pericarditis and myocarditis in a population-based cohort of inpatients with coeliac diseaseJ Intern Med2007262545554[PubMed][Google Scholar]
135. ZahmatkeshanMFallahpoorMAmoozgarHPrevalence of celiac disease in children with idiopathic dilated cardiomyopathyIran J Pediatr201424587592[PubMed][Google Scholar]
136. PicchiAPasqualiniPD’AielloICorteseBMicheliALimbrunoUAcute ST-elevation myocardial infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic riskThromb Haemost20089911161118[PubMed][Google Scholar]
137. McNeillADuthieFGallowayDJSmall bowel infarction in a patient with coeliac diseaseJ Clin Pathol200659216218[PubMed][Google Scholar]
138. SaylanBCevikAKirsacliogluCTEkiciFTosunOUstundagGSubclinical cardiac dysfunction in children with coeliac disease: is the gluten-free diet effective?ISRN Gastroenterol20122012706937[PubMed][Google Scholar]
139. EfeTHErtemAGCoskunYBilginMAlgulEBetonOAsarcikliLDEratMAyturkMYukselIAtrial Electromechanical Properties in Coeliac DiseaseHeart Lung Circ201625160165[PubMed][Google Scholar]
140. Cenk S, Aylin DB, Fatma Ebru A, Nihal AB, Sevil ÖS, Serdal B, Emine B, Hüseyin A, Telat K, Tahir D, Osman E, Engin BAssessment of left ventricular function by strain-strain rate echocardiography in patients with celiac diseaseTurk J Med Sci201444173177[PubMed][Google Scholar]
141. AkinFESariCOzer-SariSDemirezer-BolatADurmazTKelesTErsoyOBozkurtEThe evaluation of left ventricular functions with tissue doppler echocardiography in adults with celiac diseaseSaudi J Gastroenterol201622116121[PubMed][Google Scholar]
142. CuocoLMuriagoMCastamanRDi MuzioDVescovoGSalvagniniMPA. 35 High prevalence of asymptomatic mitral valve prolapse in untreated celiac disease patientsDig Liver Dis200840S88[Google Scholar]
143. FathyAAbo-HadedHMAl-AhmadiNEl-SonbatyMMCardiac functions assessment in children with celiac disease and its correlation with the degree of mucosal injury: Doppler tissue imaging studySaudi J Gastroenterol201622441447[PubMed][Google Scholar]
144. LionettiECatassiCFrancavillaRMiraglia Del GiudiceMSciaccaPArrigoTLeonardiSSalpietroASalpietroCLa RosaMSubclinic cardiac involvement in paediatric patients with celiac disease: a novel sign for a case finding approachJ Biol Regul Homeost Agents201226S63S68[PubMed][Google Scholar]
145. OzturkKAltunBKurtOArterial stiffness in patients with celiac diseaseEur J Gastroenterol Hepatol20152714791480[Google Scholar]
146. LudvigssonJFJamesSAsklingJStenestrandUIngelssonENationwide cohort study of risk of ischemic heart disease in patients with celiac diseaseCirculation2011123483490[PubMed][Google Scholar]
147. EmilssonLCarlssonRHolmqvistMJamesSLudvigssonJFThe characterisation and risk factors of ischaemic heart disease in patients with coeliac diseaseAliment Pharmacol Ther201337905914[PubMed][Google Scholar]
148. LagroJDuijtsLJaddoeVWLetter by Lagro et al regarding article, “Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease”Circulation2011124e422; author reply e423[PubMed][Google Scholar]
149. EmilssonLJamesSLudvigssonJFIschaemic heart disease in first-degree relatives to coeliac patientsEur J Clin Invest201444359364[PubMed][Google Scholar]
150. BardellaMTCantùPCesanaBMPiodiLPSevere heart disease in coeliac sprue and inflammatory Bowel disease: a common pathogenesis?Scand J Gastroenterol20043913041305[PubMed][Google Scholar]
151. LebwohlBEmilssonLFröbertOEinsteinAJGreenPHLudvigssonJFMucosal healing and the risk of ischemic heart disease or atrial fibrillation in patients with celiac disease; a population-based studyPLoS One201510e0117529[PubMed][Google Scholar]
152. LebwohlBEmilssonLFröbertOEinsteinAJGreenPHLudvigssonJSu1437 Mucosal Healing and Risk of ischemic heart disease in celiac disease: A population-based cohort studyGastroenterology2014146S469[Google Scholar]
153. Bayar N, Çekin AH, Arslan Ş, Çağırcı G, Erkal Z, Çay S, Köklü E, Küçükseymen SAssessment of Left Atrial Function in Patients with Celiac DiseaseEchocardiography20153218021808[PubMed][Google Scholar]
154. Yayla Ç, Yüksel M, Yayla KG, Açikgöz SK, Akboga MK, Kaplan M, Coskun O, Akpinar MY, Yalinkiliç ZM, Turak O, Kayaçetin EPP-138 Assessment of Tp-e interval and Tp-e/QT Ratio in Patients with Celiac DiseaseAm J Cardiol2016117S88[Google Scholar]
155. GajulapalliRDPrevalence of atrial fibrillation in patient with celiac diseaseCirculation2014130Suppl 2A12318[Google Scholar]
156. EmilssonLSmithJGWestJMelanderOLudvigssonJFIncreased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort studyEur Heart J20113224302437[PubMed][Google Scholar]
157. MahMWPrielIEHumenDPBrownNESprouleBJIdiopathic pulmonary hemosiderosis, complete heart block and celiac diseaseCan J Cardiol19895191194[PubMed][Google Scholar]
158. KumharMKumarCKulkarniDCeliac disease in association with a congenital heart diseaseInt J Celiac Dis201311416[Google Scholar]
159. ShahramianIDehghaniSMHaghighatMNooriNMTeimouriASharafiEKaliliMKalvandiGSerological Evaluation of Celiac Disease in Children with Congenital Heart Defect; A Case Control StudyMiddle East J Dig Dis2015798103[PubMed][Google Scholar]
160. NooriNMTeimouriANakhaey MoghaddamMShahrakiTThe prevalence of celiac disease in down syndrome children with and without congenital heart defectsInt J Pediatr2016421432152[Google Scholar]
161. CongdonPJFiddlerGILittlewoodJMScottOCoeliac disease associated with congenital heart diseaseArch Dis Child1982577879[PubMed][Google Scholar]
162. BarbatoMViolaFCurioneMDi BonaSAmbrosiniAManciniVBasciettoCCucchiaraSP0428 Cardiac sympathetic and parasympathetic balance before and after gluten free diet in children with celiac disease. JPediatr Gastroenterol Nutr200439S218[Google Scholar]
163. PennyHAFerrarMAtkinsonJHoggardNHadjivassiliouMWestJNSandersDSPTU-184 Is there a relationship between gluten ingestion and postural tachycardia syndrome?Gut201564Suppl 1A144[Google Scholar]
164. PennyHAAzizIFerrarMAtkinsonJHoggardNHadjivassiliouMWestJNSandersDSPWE-055 Coeliac disease is more common in subjects with postural orthostatic tachycardia syndrome compared to healthy controlsGut201665Suppl 1A165A166[Google Scholar]
165. StöllbergerCFinstererJIschemic stroke in left ventricular noncompaction and celiac diseaseInt J Cardiol2014176534536[PubMed][Google Scholar]
166. PolatTBUrganciNYalcinYZeybekCAkdenizCErdemAImanovECelebiACardiac functions in children with coeliac disease during follow-up: insights from tissue Doppler imagingDig Liver Dis200840182187[PubMed][Google Scholar]
167. NorsaLShamirRZevitNGluten-free diet in celiac disease: protective or providing additive risk factors for the development of cardiovascular disease?Nutr Ther Metabol20123019[Google Scholar]
168. VangaRRKabbaniTAMukherjeeRVillafuerte-GalvezJAPallavKDennisMKellyCPLefflerDASa1258 Risk of cardiovascular disease in individuals with celiac diseaseGastroenterology2013144S244[Google Scholar]
169. WeiLSpiersEReynoldsNWalshSFaheyTMacDonaldTMThe association between coeliac disease and cardiovascular diseaseAliment Pharmacol Ther200827514519[PubMed][Google Scholar]
170. ZweigBMShethMSimpsonSAl-MallahMHAssociation of abdominal aortic calcium with coronary artery calcium and obstructive coronary artery disease: a pilot studyInt J Cardiovasc Imaging201228399404[PubMed][Google Scholar]
171. SteinACLiaoCPaskiSPolonskyTSemradCEKupferSSObesity and Cardiovascular Risk in Adults With Celiac DiseaseJ Clin Gastroenterol201650545550[PubMed][Google Scholar]
172. ZaniniBMazzonciniECaselaniFMagniARicciCLanziniAEffect of gluten free diet (GFD) on cardiovascular risk factors: Results in a cohort of 765 celiac disease (CD) patientsGastroenterology2011140S444[Google Scholar]
173. CipilHBaydarIAltinkaynakKAdemogluELalogluEFilizMSanibasAVYildizFSevimliHArslanMMean platelet volume in a patient with celiac disease: The relationship between metabolic syndrome, impaired fasting glucose and cardiovascular riskEndoc Abstr201641EP788[Google Scholar]
174. LewisNRLoganRFSandersDSHubbardRBHolmesGKWestJVascular risk profile in incident coeliac disease and change with gluten-free dietGut201160Suppl 1A87A88[Google Scholar]
175. LudvigssonJFde FaireUEkbomAMontgomerySMVascular disease in a population-based cohort of individuals hospitalised with coeliac diseaseHeart20079311111115[PubMed][Google Scholar]
176. AssaAFrenkel-NirYTzurDKatzLHShamirRCardiovascular Risk Factors in Adolescents With Celiac Disease: A Cross Sectional Population Based StudyJ Pediatr Gastroenterol Nutr2016Epub ahead of print[Google Scholar]
177. WarnckeKLiptaySFröhlich-ReitererEScheuingNSchebekMWolfJRohrerTRMeissnerTHollRWVascular risk factors in children, adolescents, and young adults with type 1 diabetes complicated by celiac disease: results from the DPV initiativePediatr Diabetes201617191198[PubMed][Google Scholar]
178. LeedsJSHopperADHadjivasslliouMTesfayeSSandersDSWhat are the implications of newly-identified coeliac disease in patients with type 1 diabetes mellitus? Effect on glycaemic control, quality of life, cardiac risk factors and peripheral nerve functionProceedings Nutr Society200968E56[Google Scholar]
179. NorsaLShamirRZevitNVerduciEHartmanCGhisleniDRivaEGiovanniniMCardiovascular disease risk factor profiles in children with celiac disease on gluten-free dietsWorld J Gastroenterol20131956585664[PubMed][Google Scholar]
180. OmelchenkoOVFeatures of functional state of cardiovascular system in children with celiac diseaseChilds Health2013456669[Google Scholar]